The ECTRIMS Podcast
von The European Committee for Treatment and Research in Multiple Sclerosis
- wöchentlichErscheinungsrhythmus
- 23 mintypische Länge
- vor 2 Tagenletzte Folge
The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
Folgen
MS Nurses on the Frontline of Multiple Sclerosis Care | MSToronto2026
MS nurses are at the heart of MS care, but as treatments become more complex and demands grow, what support do they need to keep going? In this special MSToronto2026 episode, host Brett Drummond is joined by Colleen Harris, Nurse Practition
NMOSD & MOGAD: New Treatments and Hope for the Future | Patient Community Day 2026 (Part 2)
🎙️ What does the future hold for people living with NMOSD and MOGAD? With new treatments emerging and research advancing, there are important reasons for hope. As part of Patient Community Day 2026, we're pleased to share the second episod
MS Research: What's New and What Matters to Patients? | Patient Community Day 2026 (Part 1)
What does the MS community need from research – and how can we make sure the voices of people living with MS help shape what comes next? As part of Patient Community Day 2026, we're sharing a special collaborative episode from RealTalk MS a
MSToronto2026 Day Three: What Will We Take Away from Toronto?
Three days of science, debate and discovery. For the final episode in our special MSToronto2026 podcast series, ECTRIMS Executive Committee member Jaume Sastre-Garriga joins host Brett Drummond direct from Toronto. Together, they unpack the
MSToronto2026 Day Two: What Does the MS Community Need Next?
Today, our special podcast series brings together two major voices from the North American MS community: • Tim Coetzee, National Multiple Sclerosis Society • Pamela Valentine, MS Canada Scientific progress in MS is accelerating. But is that
Day One Highlights: From Imaging to Biology with Daniel Reich
Day One at MSToronto2026 – and we're taking you inside one of the meeting's headline lectures. Our special MSToronto2026 podcast series continues with Daniel Reich – the MSToronto2026 Lecturer – as he joins host Brett Drummond to reflect on
MSToronto2026 Pre-Day Highlights with Ann Yeh
The ECTRIMS Podcast is on the ground at MSToronto2026 – bringing you the conversations, insights and highlights as they happen. Kicking off our special MSToronto2026 Joint Meeting Series, Ann Yeh joins host Brett Drummond direct from Toront
Can We Detect MS Progression in Real Time?
Can clinicians identify MS progression as it happens, or does confirming meaningful disability worsening require months of observation? Early recognition of multiple sclerosis (MS) progression is critical to informing clinical decisions. Ye
Sandra Vukusic Named 2026 Rachel Horne Prize Winner
Prof. Sandra Vukusic has been named the 2026 recipient of the Rachel Horne Prize for Women's Research in MS. In this special episode of the ECTRIMS Podcast, Sandra joins prize founder Rachel Horne and host Brett Drummond to mark the announc
The Multi-Arm Multi-Stage Advantage: Transforming Multiple Sclerosis Trials
What if clinical trials could evaluate multiple treatment approaches at the same time and adapt as evidence emerges? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Jeremy Chataway of University College London
The Blood–Brain Barrier in Multiple Sclerosis: From Dysfunction to Treatment
The blood–brain barrier is a highly specialised interface that regulates the movement of cells, molecules and nutrients between the circulation and the central nervous system. But what happens when this critical barrier becomes dysfunctiona
Predicting MS: Can Data Bring Us Closer to Personalised Care?
Can growing amounts of real-world MS data help clinicians predict disease progression and make more personalised treatment decisions? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Dr. Will Brown from Cambridge Univ
How Technology Is Transforming Multiple Sclerosis Care
Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of Johns Hopkins University and Prof. Letizia Le
Should High-Risk Populations Be Screened for Multiple Sclerosis?
Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration series, host Prof. Anneke van der Walt, C
How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey
Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still face significant barriers to diagnosis, s
MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis
Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a small number of recently published studies
Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation
Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Eric Thouvenot from U
Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?
In this episode of the ECTRIMS Podcast, recorded in collaboration with the Multiple Sclerosis Journal "Controversies in MS" series, host Prof. Anneke van der Walt moderates a discussion between Prof. Andy Solomon and Prof. Enrique Gómez on
EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?
Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the future of treatment and prevention? In t
Fenebrutinib in Relapsing MS: FENhance Trial Results Explained
New Phase 3 data presented at the AAN conference 2026 provide compelling evidence that fenebrutinib may represent a high-efficacy oral treatment option for people living with relapsing multiple sclerosis. In this exclusive episode, leading
How MRI and OCT are Changing Multiple Sclerosis Diagnosis, Prognosis, and Treatment
Imaging techniques in multiple sclerosis are evolving rapidly, with MRI and emerging biomarkers playing a central role in diagnosis, prognosis and disease monitoring. In this episode of the ECTRIMS Podcast, neurologist Gabriel Bsteh and hos
Does the Label Given to My MS Disease Course Matter?
How much do the labels used to describe multiple sclerosis actually reflect the lived experience of people affected by the disease? In this first episode of the new ECTRIMS–MS Journal collaboration series, host Dr. Anneke van der Walt, Cont
Rehabilitation in MS and the Case for Early Intervention
Rehabilitation is more than exercise – it is a personalised process of learning and adaptation that empowers people living with MS to maximise independence, participation and quality of life. In this episode – recorded at ECTRIMS 2025 in Ba
Fenebrutinib in PPMS: Insights from ACTRIMS Forum 2026
Clinical trial results unveiled today at ACTRIMS Forum 2026 suggest that fenebrutinib may be a novel and effective treatment option for people living with primary progressive multiple sclerosis. In this exclusive episode providing the first
Harnessing the Gut Microbiome in MS: From Insight to Intervention
What role does the gut microbiome play in multiple sclerosis — and how close are we to translating microbiome research into meaningful clinical interventions? In this episode of the ECTRIMS Podcast, host Brett Drummond is joined by Mahesh D
How well are we measuring cognition in MS?
Cognitive change is one of the most common—and most misunderstood—symptoms of multiple sclerosis. In this episode, host Brett Drummond is joined by Dr. Vicki Levitt (Columbia University) and Dr. Tom Fuchs (MS Center Amsterdam) to explore wh
MS Nursing: Listening, Leadership, and the Role of AI in Patient Care
At every stage of the MS journey, nurses are the steady link between patients, families, and the healthcare team. In this episode, host Brett Drummond speaks with Amy Perrin Ross, MS Specialist Nurse and Program Coordinator at Loyola Univer
Why We Need to Talk More About Mental Health in MS
While much of MS care focuses on physical symptoms, mental health challenges—like depression, anxiety, loneliness, and stigma—often go under-recognised. In this episode, host Brett Drummond speaks with Dr. Rebecca MaGuire, psychologist and
MS Research Through the Patient Lens: Key Takeaways from Patient Community Day 2025
Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancing effective treatments. After the event
Can We Repair Myelin in Multiple Sclerosis? Results from the CCMR-Two Trial
Can damaged myelin be repaired in people living with multiple sclerosis? Results from the CCMR-Two clinical trial presented at ECTRIMS 2025 offered promising new evidence for remyelination using a combination of metformin and clemastine. St
